Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 4
2018 2
2019 10
2020 11
2021 19
2022 11
2023 9
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.
Piccini JP, Caso V, Connolly SJ, Fox KAA, Oldgren J, Jones WS, Gorog DA, Durdil V, Viethen T, Neumann C, Mundl H, Patel MR; PACIFIC-AF Investigators. Piccini JP, et al. Lancet. 2022 Apr 9;399(10333):1383-1390. doi: 10.1016/S0140-6736(22)00456-1. Epub 2022 Apr 3. Lancet. 2022. PMID: 35385695 Clinical Trial.
The Reply.
Gue Y, Lip GYH. Gue Y, et al. Am J Med. 2024 Mar;137(3):e61. doi: 10.1016/j.amjmed.2023.11.024. Am J Med. 2024. PMID: 38403380 No abstract available.
Fibrinolysis in Platelet Thrombi.
Kanji R, Gue YX, Memtsas V, Gorog DA. Kanji R, et al. Among authors: gue yx. Int J Mol Sci. 2021 May 12;22(10):5135. doi: 10.3390/ijms22105135. Int J Mol Sci. 2021. PMID: 34066261 Free PMC article. Review.
Adherence to the 'Atrial Fibrillation Better Care' Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients.
Romiti GF, Pastori D, Rivera-Caravaca JM, Ding WY, Gue YX, Menichelli D, Gumprecht J, Kozieł M, Yang PS, Guo Y, Lip GYH, Proietti M. Romiti GF, et al. Among authors: gue yx. Thromb Haemost. 2022 Mar;122(3):406-414. doi: 10.1055/a-1515-9630. Epub 2021 Jun 21. Thromb Haemost. 2022. PMID: 34020488 Free article.
Stroke prevention in atrial fibrillation.
Lip GYH, Gue Y, Zhang J, Chao TF, Calkins H, Potpara T. Lip GYH, et al. Among authors: gue y. Trends Cardiovasc Med. 2022 Nov;32(8):501-510. doi: 10.1016/j.tcm.2021.10.001. Epub 2021 Oct 5. Trends Cardiovasc Med. 2022. PMID: 34619337 Review.
Crizanlizumab: A CRITICAL Drug During a CRITICAL Time?
Gue YX, Pula G, Lip GYH. Gue YX, et al. JACC Basic Transl Sci. 2021 Dec 27;6(12):946-947. doi: 10.1016/j.jacbts.2021.10.013. eCollection 2021 Dec. JACC Basic Transl Sci. 2021. PMID: 35024499 Free PMC article.
63 results